Johnson & Johnson (NYSE:JNJ) fell ~3% in early trading on Wednesday, marking its biggest intraday drop since July 2023, even as the healthcare giant posted better-than-expected financials for Q4 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback